Please join us for an insightful and practical webinar designed to enhance the confidence of general practice and community pharmacists in using the evidence-based hyperbolic tapering approach to safely reduce or stop patients’ use of psychotropic medications, whilst managing withdrawal symptoms and ensuring patient safety.

Presented By: Dr Mark Horowitz –

Dr Horowitz, Clinical Research Fellow in Psychiatry with the NHS in the UK, Visiting Lecturer in Psychopharmacology at King’s College, London, and author of Royal College of Psychiatrists’ guidance on “Stopping Antidepressants”, known as The Maudsley Deprescribing Guidelines.

Learning Outcomes:

1. Outline when deprescribing antidepressants and other psychotropic medication may be a recommended approach to care for a patient.
2. Describe risks associated with stopping psychotropic medication without adequate tapering.
3. Identify distinction between withdrawal effects from psychotropic medication and relapse of an underlying mental health condition. 
4. Summarise current principles in safe tapering psychotropic medication, including different classes of drugs and adjustments required for individual patients.

Target audience: GPs, Nurses, Practice Managers, Pharmacists, Pratice Staff

*Please note GP Registrars who wish to register for CPD events and do not have a member number will need to contact the CPD Department on 1300 986 991